Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Xiaojuan LiStephen R ColeAbhijit V KshirsagarJason P FineTil StürmerM Alan Brookhart

Published in: Clinical journal of the American Society of Nephrology : CJASN (2019)

Among dialysis patients surviving 90 days, subsequent intravenous iron administration strategies promoting more intensive iron treatment at moderate-to-high iron indices levels are associated with higher risks of mortality and infection-related events.

Keyphrases

end stage renal disease
chronic kidney disease
iron deficiency
peritoneal dialysis
high dose
ejection fraction
prognostic factors
high intensity
low dose
patient reported outcomes
combination therapy
replacement therapy